company background image
SEARL logo

Searle KASE:SEARL Stock Report

Last Price

PK₨52.87

Market Cap

PK₨20.9b

7D

0.3%

1Y

0.7%

Updated

27 Mar, 2024

Data

Company Financials +

The Searle Company Limited

KASE:SEARL Stock Report

Market Cap: PK₨20.9b

SEARL Stock Overview

The Searle Company Limited manufactures and sells pharmaceutical and other consumer products in Pakistan.

SEARL fundamental analysis
Snowflake Score
Valuation0/6
Future Growth4/6
Past Performance1/6
Financial Health2/6
Dividends0/6

The Searle Company Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Searle
Historical stock prices
Current Share PricePK₨52.87
52 Week HighPK₨64.09
52 Week LowPK₨34.22
Beta0.83
1 Month Change0.019%
3 Month Change0.69%
1 Year Change0.69%
3 Year Change-65.22%
5 Year Change-61.22%
Change since IPO1,279.31%

Recent News & Updates

Recent updates

Shareholder Returns

SEARLPK PharmaceuticalsPK Market
7D0.3%0.2%-0.04%
1Y0.7%20.1%49.2%

Return vs Industry: SEARL underperformed the PK Pharmaceuticals industry which returned 20.1% over the past year.

Return vs Market: SEARL underperformed the PK Market which returned 49.2% over the past year.

Price Volatility

Is SEARL's price volatile compared to industry and market?
SEARL volatility
SEARL Average Weekly Movement6.8%
Pharmaceuticals Industry Average Movement5.1%
Market Average Movement5.4%
10% most volatile stocks in PK Market8.6%
10% least volatile stocks in PK Market3.6%

Stable Share Price: SEARL has not had significant price volatility in the past 3 months.

Volatility Over Time: SEARL's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of PK stocks.

About the Company

FoundedEmployeesCEOWebsite
19652,716Syed Ahmedhttps://www.searlecompany.com

The Searle Company Limited manufactures and sells pharmaceutical and other consumer products in Pakistan. The company offers pharmaceutical products in the therapeutic areas of cardiovascular, respiratory care, gastroenterology, pain management, CNS, orthocare, neuropsychiatry, probiotics, antibiotics, and nutritional care. It also provides nutraceutical products, as well as medical devices and disposables.

The Searle Company Limited Fundamentals Summary

How do Searle's earnings and revenue compare to its market cap?
SEARL fundamental statistics
Market capPK₨20.92b
Earnings (TTM)PK₨313.71m
Revenue (TTM)PK₨33.90b

65.7x

P/E Ratio

0.6x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
SEARL income statement (TTM)
RevenuePK₨33.90b
Cost of RevenuePK₨20.67b
Gross ProfitPK₨13.23b
Other ExpensesPK₨12.91b
EarningsPK₨313.71m

Last Reported Earnings

Jun 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)0.80
Gross Margin39.02%
Net Profit Margin0.93%
Debt/Equity Ratio60.8%

How did SEARL perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.